Key result
Comorbid heart failure linked to ~56% higher all-cause mortality in rheumatoid arthritis.
Why the study?
Rheumatoid arthritis patients have a significantly elevated risk of heart failure, but population-level evidence and underlying mechanisms remain unclear.
Does IL15RA mediate the pathophysiological link between rheumatoid arthritis and heart failure, and can dioscin reduce this inflammatory pathway?
Observational (n=2,931)
Does IL15RA mediate the pathophysiological link between rheumatoid arthritis and heart failure, and can dioscin reduce this inflammatory pathway?
IL15RA is identified as a shared pathogenic hub linking rheumatoid arthritis to heart failure, and the dietary phytochemical dioscin demonstrates preclinical efficacy in attenuating this inflammatory axis.
Answers are grounded in this paper and cite their sources.
Comorbid heart failure signals higher mortality in rheumatoid arthritis, warranting vigilance; leaves open whether IL15RA-targeted therapies like dioscin improve outcomes.
Purpose Rheumatoid arthritis (RA) patients face a significantly elevated risk of heart failure (HF), but population-level evidence and underlying mechanisms remain unclear. We aimed to assess the RA-HF association using national data and identify dietary compounds targeting shared inflammatory pathways. Methods We analyzed NHANES data (n=2,931) and performed two-sample Mendelian randomization (MR). Integrated machine learning, single-cell transcriptomics, clinical samples, and in vitro experiments identified therapeutic targets and evaluated the effectiveness of dioscin (a yam-derived saponin). Results The rate of HF in RA patients is high, and RA patients with HF have a worse prognosis. MR analysis also revealed that RA was a significant HF risk factor. IL15RA emerged as a shared causal target, whose silencing suppressed TNF-α-induced ICAM-1 in endothelial cells and reduced M1 (CD86 + ) macrophage polarization. Mechanistically, MIF signaling were strongly implicated in the crosstalk between endothelial cells and macrophages. Dioscin bound IL15RA and reduced its expression in both cell types, phenocopying IL15RA silencing. Conclusion This study identifies IL15RA as a key therapeutic target linking RA and HF, and dioscin as a dietary phytochemical with anti-inflammatory potential. Our findings provide a population-based framework and a readily translatable nutritional strategy for mitigating cardiac comorbidity in RA patients.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2026) conducted an observational in Rheumatoid arthritis and heart failure (n=2,931). Heart failure vs. Without heart failure was evaluated on All-cause mortality (HR 1.56, 95% CI 1.29-1.88, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: